Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 20, 2018
Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)Ersin Ozaslan, Metin Ozkan, Irfan Cicin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2014
Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO)Olcun Umit Unal, Ilhan Oztop, Tugba Kos, et al.
Thoracic Cancer|August 15, 2015
Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)Olcun Umit Unal, Ilhan Oztop, Nurgul Yasar, et al.
Journal of Chemotherapy (Florence, Italy)|October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Onkologie|October 6, 2012
Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapyAli O Kaya, Ugur Coskun, Metin Ozkan, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2012
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Metin Ozkan, et al.
Medical Oncology (Northwood, London, England)|June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patientsEmin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 8, 2015
Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical OncologyHatice Odabas, Arife Ulas, Kubra Aydin, et al.
World Journal of Urology|November 5, 2016
Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumorsMahmut Gumus, Ahmet Bilici, Hatice Odabas, et al.
Onkologie|December 5, 2012
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experienceBulent Cetin, Mustafa Benekli, Berna Oksuzoglu, et al.
Pageof 13